Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.19.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock [Member]
Common Stock [Member]
Shares Issuable [Member]
Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Balance at Dec. 31, 2017 $ 120,502 $ 1 $ 51 $ 500 $ 364,148 $ (312,127) $ 67,929
Balance (in shares) at Dec. 31, 2017   1,000,000 50,991,285        
Stock-based compensation expense 4,795 $ 0 $ 0 0 4,795 0 0
Issuance of restricted stock 0 $ 0 $ 1 0 (1) 0 0
Issuance of restricted stock (in shares)   0 1,472,440        
Issuance of subsidiaries' common shares for license expenses 22 $ 0 $ 0 0 22 0 0
Subsidiary's offering, net 20,844 0 0 0 20,844 0 0
Exercise of subsidiary's warrants for cash 96 0 0 0 96 0 0
Issuance of common stock for at-the-market offering, net 318 0 $ 0 0 318 0 0
Issuance of common stock for at-the-market offering, net (in shares)     64,797        
At-the-market offering cost (6) 0 $ 0 0 (6) 0 0
Preferred A dividends declared and paid (586) 0 0 0 (586) 0 0
Common shares issuable for 2017 Subordinated Note Financing interest expense 489 0 0 489 0 0 0
Common shares issued for 2017 Subordinated Note Financing interest expense 0 $ 0 $ 0 (500) 500 0 0
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   0 158,015        
–Disposal of National (710) $ 0 $ 0 0 (710) 0 0
Non-controlling interest in subsidiaries 0 0 0 0 (15,166) 0 15,166
Net loss attributable to non-controlling interest (17,200) 0 0 0 0 0 (17,200)
Net income (loss) attributable to common stockholders (21,018) 0 0 0 0 (21,018) 0
Balance at Mar. 31, 2018 107,546 $ 1 $ 52 489 374,254 (333,145) 65,895
Balance (in shares) at Mar. 31, 2018   1,000,000 52,686,537        
Balance at Dec. 31, 2017 120,502 $ 1 $ 51 500 364,148 (312,127) 67,929
Balance (in shares) at Dec. 31, 2017   1,000,000 50,991,285        
Net loss attributable to non-controlling interest (57,789)            
Balance at Dec. 31, 2018 19,743 $ 1 $ 58 659 397,408 (396,274) 17,891
Balance (in shares) at Dec. 31, 2018   1,000,000 57,845,447        
Stock-based compensation expense 3,309 $ 0 $ 0 0 3,309 0 0
Issuance of restricted stock 0 $ 0 $ 2 0 (2) 0 0
Issuance of restricted stock (in shares)   0 1,609,325        
Issuance of subsidiaries' common shares for license expenses 0 $ 0 $ 0 (164) 164 0 0
Issuance of common stock for at-the-market offering, net 6,142 0 $ 3 0 6,139 0 0
Issuance of common stock for at-the-market offering, net (in shares)     2,927,427        
Preferred A dividends declared and paid (586) 0 $ 0 0 (586) 0 0
Partner company's sale of stock, net 31,499 0 0 0 31,499 0 0
Partner company's at-the-market offering, net 355 0 0 0 355 0 0
Issuance of partner company warrants in conjunction with Horizon Notes 888       888    
Common shares issuable for 2017 Subordinated Note Financing interest expense 484 0 0 484 0 0 0
Common shares issued for 2017 Subordinated Note Financing interest expense 0 $ 0 $ 0 (495) 495 0 0
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   0 744,322        
Common shares issuable for Opus interest expense 281 $ 0 $ 0 281 0 0 0
Common shares issuable for Opus interest expense (in shares)   0 0        
Non-controlling interest in subsidiaries 0 $ 0 $ 0 0 (24,799) 0 24,799
Deconsolidation of Caelum non-controlling interest 4,849 0 0 0 0 0 4,849
Net loss attributable to non-controlling interest (17,647) 0 0 0 0 0 (17,647)
Net income (loss) attributable to common stockholders 1,392 0 0 0 0 1,392 0
Balance at Mar. 31, 2019 $ 50,709 $ 1 $ 63 $ 765 $ 414,870 $ (394,882) $ 29,892
Balance (in shares) at Mar. 31, 2019   1,000,000 63,126,521